Accel Wealth Management Ginkgo Bioworks Holdings, Inc. Transaction History
Accel Wealth Management
- $243 Million
- Q2 2024
A detailed history of Accel Wealth Management transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Accel Wealth Management holds 14,350 shares of DNA stock, worth $119,535. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,350Holding current value
$119,535% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DNA
# of Institutions
341Shares Held
925MCall Options Held
1.04MPut Options Held
2.23M-
Viking Global Investors LP143MShares$1.19 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA139MShares$1.16 Billion0.0% of portfolio
-
Baillie Gifford & CO134MShares$1.12 Billion0.04% of portfolio
-
Anchorage Capital Group, L.L.C. New York, NY69.9MShares$582 Million7.28% of portfolio
-
Black Rock Inc. New York, NY42MShares$350 Million0.0% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $10.7B
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...